HHS Secretary Robert F. Kennedy Jr. plans to axe members of the department’s vaccine-centric panels of outside advisers who he deems to be too cozy with the drug industry.
A meeting of vaccine advisers set for late February has been postponed, a federal official confirmed on Thursday, raising new ...
GSK's Penmenvy wins FDA approval to protect against five meningococcal serogroups. The CDC panel will vote on usage ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results